These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 497404)

  • 21. Aequorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation-dependent calcium movement in response to ADP.
    Lecompte T; Potevin F; Champeix P; Morel MC; Favier R; Hurtaud MF; Schlegel N; Samama M; Kaplan C
    Thromb Res; 1990 Jun; 58(6):561-70. PubMed ID: 2117306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation of ADP in the binding of fibrinogen to thrombin-stimulated platelets.
    Plow EF; Marguerie GA
    Blood; 1980 Sep; 56(3):553-5. PubMed ID: 7407418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B.
    Peerschke EI; Zucker MB
    Thromb Haemost; 1980 Feb; 43(1):58-60. PubMed ID: 7404479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.
    Cattaneo M; Canciani MT; Lecchi A; Kinlough-Rathbone RL; Packham MA; Mannucci PM; Mustard JF
    Blood; 1990 Mar; 75(5):1081-6. PubMed ID: 2137716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
    Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
    Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen interaction with platelet receptors.
    Niewiarowski S; Kornecki E; Budzynski AZ; Morinelli TA; Tuszynski GP
    Ann N Y Acad Sci; 1983 Jun; 408():536-55. PubMed ID: 6307105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteolysis of the platelet surface: dissociation of shape change from aggregation.
    Kornecki E; Ehrlich YH; Hardwick DH; Lenox RH
    Am J Physiol; 1986 Apr; 250(4 Pt 2):H550-7. PubMed ID: 3008579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between fibrinogen binding to human platelets and platelet aggregability.
    Peerschke EI; Zucker MB; Grant RA; Egan JJ; Johnson MM
    Blood; 1980 May; 55(5):841-7. PubMed ID: 6767512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
    Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
    Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents.
    Greenberg JP; Packham MA; Guccione MA; Harfenist EJ; Orr JL; Kinlough-Rathbone RL; Perry DW; Mustard JF
    Blood; 1979 Oct; 54(4):753-65. PubMed ID: 113045
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on platelets of patients with inherited platelet disorders suggest that collagen-induced fibrinogen binding to membrane receptors requires secreted ADP but not released alpha-granule proteins.
    Legrand C; Nurden AT
    Thromb Haemost; 1985 Oct; 54(3):603-6. PubMed ID: 3003952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chymotrypsin on the release reaction and aggregation of blood platelets.
    Grant RA; Zucker MB
    Proc Soc Exp Biol Med; 1980 Oct; 165(1):114-7. PubMed ID: 7422669
    [No Abstract]   [Full Text] [Related]  

  • 36. Exposure of fibrinogen receptor on human platelets by proteolytic enzymes.
    Niewiarowski S; Budzynski AZ; Morinelli TA; Brudzynski TM; Stewart GJ
    J Biol Chem; 1981 Jan; 256(2):917-25. PubMed ID: 6256372
    [No Abstract]   [Full Text] [Related]  

  • 37. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa.
    Kornecki E; Tuszynski GP; Niewiarowski S
    J Biol Chem; 1983 Aug; 258(15):9349-56. PubMed ID: 6308003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation.
    Musial J; Niewiarowski S; Hershock D; Morinelli TA; Colman RW; Edmunds LH
    J Lab Clin Med; 1985 Apr; 105(4):514-22. PubMed ID: 2984300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.